Cell line · CVCL_0152

AsPC-1

Cancer cell line, Homo sapiens. Pancreatic ductal adenocarcinoma. 220 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Cite this record

ConductScience Library. AsPC-1. Cell lines, record CVCL_0152. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0152

On this page

Cell line

As Cellosaurus gives it.

Name: AsPC-1
Accession: CVCL_0152
RRID: RRID:CVCL_0152
Synonyms: AsPc-1, Aspc-1, ASPC-1, As-PC1, ASPC1, AsPC1, Aspc1, AsPc1
Species: Homo sapiens (Human)
Sex: Female
Age at sampling: 62Y
Category: Cancer cell line
Diseases: Pancreatic ductal adenocarcinoma (NCIt C9120)
Derived from: Ascites (metastatic)
Entry created: 2012-04-04
Entry updated: 2026-06-25

Source Cellosaurus

Problems1

Problem	Cellosaurus's note
Caution	TP53 mutation indicated incorrectly as being at c.818G>A in PubMed=1630814.

Source Cellosaurus

Papers220

Paper	Journal	Year	How we know	Source
Long Noncoding RNA LINC00941 Links Oncogenic KRAS Signaling to Aggressiveness, DNA Repair, and Chemoresistance in Pancreatic Cancer	IUBMB Life	2026	Its Methods give the RRID and name the line	PubMed
Pharmacokinetic Tuning Redirects β‐Lapachone From NQO1 Bioactivation to Vimentin‐Targeted Oxidation in Cancer	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
Selective AUTAC-mediated ATP7B degradation unlocks cuproptosis vulnerability in pancreatic ductal adenocarcinoma.	Clin Transl Med	2026	Its Methods give the RRID and name the line	PubMed
Targeting SERPINB5 and MSLN for Pancreatic Cancer Therapy.	Cancers (Basel)	2026	Its Methods give the RRID and name the line	PubMed
Differential Sensitivity to xCT-inhibition by ME1 expression.	Mol Cancer Ther	2026	Its Methods give the RRID and name the line	PubMed
Dual Targeting of FGFR4 and PI3K-mTOR Suppresses Tumor-Associated Phenotypes in Pancreatic Ductal Adenocarcinoma.	Int J Mol Sci	2026	Its Methods give the RRID and name the line	PubMed
Discovery and Optimization of AMT-676, a CDH17-Targeting ADC for the Treatment of Advanced Gastrointestinal Cancers.	Adv Sci (Weinh)	2026	Its Methods give the RRID and name the line	PubMed
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.	Mol Cancer Ther	2026	Its Methods give the RRID and name the line	PubMed
Targeting Oncogenic KRAS Using Peptide Nucleic Acid Oligomers Attached to Cell-Penetrating Peptides.	Int J Mol Sci	2026	Its Methods give the RRID and name the line	PubMed
Glutamine-restricted diets restore sensitivity to KRASG12D inhibitor through the reversal of ANXA1 mediated metabolic reprogramming.	Cell Rep Med	2026	Its Methods give the RRID and name the line	PubMed

1 to 10 of 220

See all 220 papers

Relatives13

Relation	Cell line	Accession	Source
Derived from it	AsPC-1 SPINK1 #10	CVCL_C3NE	Cell lines
Derived from it	AsPC-1/CMV-Luc	CVCL_J243	Cell lines
Derived from it	AsPC1-R	CVCL_XX79	Cell lines
Derived from it	AsPC1/GFP	CVCL_E6XM	Cell lines
Derived from it	AsPC1/Luciferase-2A-GFP	CVCL_E6XP	Cell lines
Derived from it	AsPC1/RFP	CVCL_E6XN	Cell lines
Derived from it	EDITGENE AsPC-1-CopGFP	CVCL_F6BH	Cell lines
Derived from it	EDITGENE AsPC-1-FLUC	CVCL_F5TV	Cell lines
Derived from it	EDITGENE GPER1 Knockout AsPC-1 Cell Line	CVCL_F5BZ	Cell lines
Derived from it	HyCyte AsPC-1 KO-hCDH17	CVCL_F1MR	Cell lines

1 to 10 of 13

See all 13 relatives

Cell banks10

Cell bank	Catalog number	Source
ATCC	CRL-1682	ATCC
AddexBio	C0018023/5061	Cellosaurus
BCRC	60494	BCRC
CLS	300158	CLS
ECACC	96020930	ECACC
EDITGENE	EDC00327	EDITGENE
IBRC	C10154	Cellosaurus
IZSLER	BS TCL 171	Cellosaurus
KCLB	21682	KCLB
NCBI_Iran	C558	Cellosaurus

Data dates

The date of each source this release read.

Cellosaurus: 2026-10-22; Cellosaurus
PubMed Central's articles: 2026-11-12; PubMed Central's articles
Our copy of PubMed: 2026-11-06; Our copy of PubMed

Sources 4

CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
PubMedNLM's terms

Each source's terms

CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0152

GET https://conductscience.org/api/cell-lines/v1/CVCL_0152/papers?page=2

API reference For AI assistants